Cargando…

Human Spinal Oligodendrogenic Neural Progenitor Cells Enhance Pathophysiological Outcomes and Functional Recovery in a Clinically Relevant Cervical Spinal Cord Injury Rat Model

Traumatic spinal cord injury (SCI) results in the loss of neurons, oligodendrocytes, and astrocytes. Present interventions for SCI include decompressive surgery, anti-inflammatory therapies, and rehabilitation programs. Nonetheless, these approaches do not offer regenerative solutions to replace the...

Descripción completa

Detalles Bibliográficos
Autores principales: Pieczonka, Katarzyna, Nakashima, Hiroaki, Nagoshi, Narihito, Yokota, Kazuya, Hong, James, Badner, Anna, Chio, Jonathon C T, Shibata, Shinsuke, Khazaei, Mohamad, Fehlings, Michael G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502566/
https://www.ncbi.nlm.nih.gov/pubmed/37616288
http://dx.doi.org/10.1093/stcltm/szad044
_version_ 1785106351002746880
author Pieczonka, Katarzyna
Nakashima, Hiroaki
Nagoshi, Narihito
Yokota, Kazuya
Hong, James
Badner, Anna
Chio, Jonathon C T
Shibata, Shinsuke
Khazaei, Mohamad
Fehlings, Michael G
author_facet Pieczonka, Katarzyna
Nakashima, Hiroaki
Nagoshi, Narihito
Yokota, Kazuya
Hong, James
Badner, Anna
Chio, Jonathon C T
Shibata, Shinsuke
Khazaei, Mohamad
Fehlings, Michael G
author_sort Pieczonka, Katarzyna
collection PubMed
description Traumatic spinal cord injury (SCI) results in the loss of neurons, oligodendrocytes, and astrocytes. Present interventions for SCI include decompressive surgery, anti-inflammatory therapies, and rehabilitation programs. Nonetheless, these approaches do not offer regenerative solutions to replace the lost cells, fiber tracts, and circuits. Neural stem/progenitor cell (NPC) transplantation is a promising strategy that aims to encourage regeneration. However, NPC differentiation remains inconsistent, thus, contributing to suboptimal functional recovery. As such, we have previously engineered oligodendrogenically biased NPCs (oNPCs) and demonstrated their efficacy in a thoracic model of SCI. Since the majority of patients with SCI experience cervical injuries, our objective in the current study was to generate human induced pluripotent stem cell-derived oNPCs (hiPSC-oNPCs) and to characterize these cells in vitro and in vivo, utilizing a clinically relevant rodent model of cervical SCI. Following transplantation, the oNPCs engrafted, migrated to the rostral and caudal regions of the lesion, and demonstrated preferential differentiation toward oligodendrocytes. Histopathological evaluations revealed that oNPC transplantation facilitated tissue preservation while diminishing astrogliosis. Moreover, oNPC transplantation fostered remyelination of the spared tissue. Functional analyses indicated improved forelimb grip strength, gait, and locomotor function in the oNPC-transplanted rats. Importantly, oNPC transplantation did not exacerbate neuropathic pain or induce tumor formation. In conclusion, these findings underscore the therapeutic potential of oNPCs in promoting functional recovery and histopathological improvements in cervical SCI. This evidence warrants further investigation to optimize and advance this promising cell-based therapeutic approach.
format Online
Article
Text
id pubmed-10502566
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-105025662023-09-16 Human Spinal Oligodendrogenic Neural Progenitor Cells Enhance Pathophysiological Outcomes and Functional Recovery in a Clinically Relevant Cervical Spinal Cord Injury Rat Model Pieczonka, Katarzyna Nakashima, Hiroaki Nagoshi, Narihito Yokota, Kazuya Hong, James Badner, Anna Chio, Jonathon C T Shibata, Shinsuke Khazaei, Mohamad Fehlings, Michael G Stem Cells Transl Med Pluripotent Stem Cells Traumatic spinal cord injury (SCI) results in the loss of neurons, oligodendrocytes, and astrocytes. Present interventions for SCI include decompressive surgery, anti-inflammatory therapies, and rehabilitation programs. Nonetheless, these approaches do not offer regenerative solutions to replace the lost cells, fiber tracts, and circuits. Neural stem/progenitor cell (NPC) transplantation is a promising strategy that aims to encourage regeneration. However, NPC differentiation remains inconsistent, thus, contributing to suboptimal functional recovery. As such, we have previously engineered oligodendrogenically biased NPCs (oNPCs) and demonstrated their efficacy in a thoracic model of SCI. Since the majority of patients with SCI experience cervical injuries, our objective in the current study was to generate human induced pluripotent stem cell-derived oNPCs (hiPSC-oNPCs) and to characterize these cells in vitro and in vivo, utilizing a clinically relevant rodent model of cervical SCI. Following transplantation, the oNPCs engrafted, migrated to the rostral and caudal regions of the lesion, and demonstrated preferential differentiation toward oligodendrocytes. Histopathological evaluations revealed that oNPC transplantation facilitated tissue preservation while diminishing astrogliosis. Moreover, oNPC transplantation fostered remyelination of the spared tissue. Functional analyses indicated improved forelimb grip strength, gait, and locomotor function in the oNPC-transplanted rats. Importantly, oNPC transplantation did not exacerbate neuropathic pain or induce tumor formation. In conclusion, these findings underscore the therapeutic potential of oNPCs in promoting functional recovery and histopathological improvements in cervical SCI. This evidence warrants further investigation to optimize and advance this promising cell-based therapeutic approach. Oxford University Press 2023-08-24 /pmc/articles/PMC10502566/ /pubmed/37616288 http://dx.doi.org/10.1093/stcltm/szad044 Text en © The Author(s) 2023. Published by Oxford University Press. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Pluripotent Stem Cells
Pieczonka, Katarzyna
Nakashima, Hiroaki
Nagoshi, Narihito
Yokota, Kazuya
Hong, James
Badner, Anna
Chio, Jonathon C T
Shibata, Shinsuke
Khazaei, Mohamad
Fehlings, Michael G
Human Spinal Oligodendrogenic Neural Progenitor Cells Enhance Pathophysiological Outcomes and Functional Recovery in a Clinically Relevant Cervical Spinal Cord Injury Rat Model
title Human Spinal Oligodendrogenic Neural Progenitor Cells Enhance Pathophysiological Outcomes and Functional Recovery in a Clinically Relevant Cervical Spinal Cord Injury Rat Model
title_full Human Spinal Oligodendrogenic Neural Progenitor Cells Enhance Pathophysiological Outcomes and Functional Recovery in a Clinically Relevant Cervical Spinal Cord Injury Rat Model
title_fullStr Human Spinal Oligodendrogenic Neural Progenitor Cells Enhance Pathophysiological Outcomes and Functional Recovery in a Clinically Relevant Cervical Spinal Cord Injury Rat Model
title_full_unstemmed Human Spinal Oligodendrogenic Neural Progenitor Cells Enhance Pathophysiological Outcomes and Functional Recovery in a Clinically Relevant Cervical Spinal Cord Injury Rat Model
title_short Human Spinal Oligodendrogenic Neural Progenitor Cells Enhance Pathophysiological Outcomes and Functional Recovery in a Clinically Relevant Cervical Spinal Cord Injury Rat Model
title_sort human spinal oligodendrogenic neural progenitor cells enhance pathophysiological outcomes and functional recovery in a clinically relevant cervical spinal cord injury rat model
topic Pluripotent Stem Cells
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502566/
https://www.ncbi.nlm.nih.gov/pubmed/37616288
http://dx.doi.org/10.1093/stcltm/szad044
work_keys_str_mv AT pieczonkakatarzyna humanspinaloligodendrogenicneuralprogenitorcellsenhancepathophysiologicaloutcomesandfunctionalrecoveryinaclinicallyrelevantcervicalspinalcordinjuryratmodel
AT nakashimahiroaki humanspinaloligodendrogenicneuralprogenitorcellsenhancepathophysiologicaloutcomesandfunctionalrecoveryinaclinicallyrelevantcervicalspinalcordinjuryratmodel
AT nagoshinarihito humanspinaloligodendrogenicneuralprogenitorcellsenhancepathophysiologicaloutcomesandfunctionalrecoveryinaclinicallyrelevantcervicalspinalcordinjuryratmodel
AT yokotakazuya humanspinaloligodendrogenicneuralprogenitorcellsenhancepathophysiologicaloutcomesandfunctionalrecoveryinaclinicallyrelevantcervicalspinalcordinjuryratmodel
AT hongjames humanspinaloligodendrogenicneuralprogenitorcellsenhancepathophysiologicaloutcomesandfunctionalrecoveryinaclinicallyrelevantcervicalspinalcordinjuryratmodel
AT badneranna humanspinaloligodendrogenicneuralprogenitorcellsenhancepathophysiologicaloutcomesandfunctionalrecoveryinaclinicallyrelevantcervicalspinalcordinjuryratmodel
AT chiojonathonct humanspinaloligodendrogenicneuralprogenitorcellsenhancepathophysiologicaloutcomesandfunctionalrecoveryinaclinicallyrelevantcervicalspinalcordinjuryratmodel
AT shibatashinsuke humanspinaloligodendrogenicneuralprogenitorcellsenhancepathophysiologicaloutcomesandfunctionalrecoveryinaclinicallyrelevantcervicalspinalcordinjuryratmodel
AT khazaeimohamad humanspinaloligodendrogenicneuralprogenitorcellsenhancepathophysiologicaloutcomesandfunctionalrecoveryinaclinicallyrelevantcervicalspinalcordinjuryratmodel
AT fehlingsmichaelg humanspinaloligodendrogenicneuralprogenitorcellsenhancepathophysiologicaloutcomesandfunctionalrecoveryinaclinicallyrelevantcervicalspinalcordinjuryratmodel